BioCentury
ARTICLE | Clinical News

Access Pharmaceuticals preclinical data

June 2, 2008 7:00 AM UTC

In animals, IV Cobalamin-targeted polymer-linked dounorubicin reduced tumor volume better than polymer-daunorubicin without the targeting group and daunorubicin alone. Data were presented at the Inter...